To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 29, 2016)
This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).
What just happenedMay 12, 2016
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 29, 2016
- May 12, 2016Committee
Referred to the Subcommittee on Health.
Health Subcommittee - May 6, 2016Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 29, 2016IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Apr 29, 2016IntroReferralH11100-A
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Apr 29, 2016IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Apr 29, 2016IntroReferralIntro-H
Introduced in House
- Apr 29, 2016IntroReferral1000
Introduced in House